Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 157

1.

Yield and mode of diagnosis of cervical intraepithelial neoplasia 3 or cancer among women with negative cervical cytology and positive high-risk human papillomavirus test results.

Pretorius RG, Belinson JL, Peterson P, Azizi F, Lo A.

J Low Genit Tract Dis. 2013 Oct;17(4):430-9. doi: 10.1097/LGT.0b013e318281f182.

PMID:
23595040
[PubMed - in process]
2.

Colposcopic management of abnormal cervical cytology and histology.

Bentley J.

J Obstet Gynaecol Can. 2012 Dec;34(12):1188-202.

PMID:
23231803
[PubMed - in process]
3.

Subsequent risk and presentation of cervical intraepithelial neoplasia (CIN) 3 or cancer after a colposcopic diagnosis of CIN 1 or less.

Pretorius RG, Peterson P, Azizi F, Burchette RJ.

Am J Obstet Gynecol. 2006 Nov;195(5):1260-5.

PMID:
17074547
[PubMed - indexed for MEDLINE]
4.

The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.

Cox JT; American Society for Colposcopy and Cervical Pathology.

Arch Pathol Lab Med. 2003 Aug;127(8):950-8.

PMID:
12952506
[PubMed - indexed for MEDLINE]
5.

Clinical validation of the Cervista HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology.

Einstein MH, Martens MG, Garcia FA, Ferris DG, Mitchell AL, Day SP, Olson MC.

Gynecol Oncol. 2010 Aug 1;118(2):116-22. doi: 10.1016/j.ygyno.2010.04.013. Epub 2010 May 21.

PMID:
20488510
[PubMed - indexed for MEDLINE]
6.

Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy.

Cox JT, Schiffman M, Solomon D; ASCUS-LSIL Triage Study (ALTS) Group.

Am J Obstet Gynecol. 2003 Jun;188(6):1406-12.

PMID:
12824970
[PubMed - indexed for MEDLINE]
7.

Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.

Verguts J, Bronselaer B, Donders G, Arbyn M, Van Eldere J, Drijkoningen M, Poppe W.

BJOG. 2006 Nov;113(11):1303-7. Epub 2006 Sep 15.

PMID:
16978225
[PubMed - indexed for MEDLINE]
8.

Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.

Castle PE, Stoler MH, Wright TC Jr, Sharma A, Wright TL, Behrens CM.

Lancet Oncol. 2011 Sep;12(9):880-90. doi: 10.1016/S1470-2045(11)70188-7. Epub 2011 Aug 22.

PMID:
21865084
[PubMed - indexed for MEDLINE]
9.

High-risk human papillomavirus detection in women with low-grade squamous intraepithelial lesions or higher-grade cytology using the Cervista HPV HR test.

Gold MA, Thomas MA, Huh WK, Sarto GE, Day SP.

J Low Genit Tract Dis. 2013 Jan;17(1):51-7. doi: 10.1097/LGT.0b013e31824ddbe0.

PMID:
22885641
[PubMed - indexed for MEDLINE]
10.

High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.

Denise Zielinski G, Snijders PJ, Rozendaal L, Voorhorst FJ, Runsink AP, de Schipper FA, Meijer CJ.

J Pathol. 2001 Oct;195(3):300-6.

PMID:
11673826
[PubMed - indexed for MEDLINE]
11.

[Use of high-risk human papillomavirus DNA testing to deal with atypical squamous cells undetermined significance and low squamous intraepithelial lesion].

Guo YL, You K, Geng L, Zhang XW, Shen XY, Yao YJ, Fan XH.

Beijing Da Xue Xue Bao. 2006 Oct 18;38(5):480-2. Chinese.

PMID:
17068618
[PubMed - indexed for MEDLINE]
Free Article
12.

[Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].

Ronco G, Biggeri A, Confortini M, Naldoni C, Segnan N, Sideri M, Zappa M, Zorzi M, Calvia M, Accetta G, Giordano L, Cogo C, Carozzi F, Gillio Tos A, Arbyn M, Mejier CJ, Snijders PJ, Cuzick J, Giorgi Rossi P.

Epidemiol Prev. 2012 May-Aug;36(3-4 Suppl 1):e1-72. Italian.

PMID:
22828243
[PubMed - indexed for MEDLINE]
13.

Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.

Juric D, Mahovlić V, Rajhvajn S, Ovanin-Rakić A, Skopljanac-Macina L, Barisić A, Projić IS, Babić D, Susa M, Corusić A, Oresković S.

Coll Antropol. 2010 Mar;34(1):19-24.

PMID:
20432728
[PubMed - indexed for MEDLINE]
14.

[The correlation of a positive DNA HPV HR test and genotyping human papilloma viruses with the presence of CIN, in women with cytologic evidence of ASC-US and LSIL].

Bedziński M, Józefiak A, Szczepańska M, Pruski D, Kedzia W, Spaczyński M.

Ginekol Pol. 2008 Jul;79(7):490-3. Polish.

PMID:
18819456
[PubMed - indexed for MEDLINE]
15.

[Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].

Qian DY, Cen JM, Wang D, Zeng RH, Lin AH, Shu YH, Hong DH, Huang ZH.

Zhonghua Fu Chan Ke Za Zhi. 2006 Jan;41(1):34-7. Chinese.

PMID:
16635326
[PubMed - indexed for MEDLINE]
16.

Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance.

ASCUS-LSIL Traige Study (ALTS) Group.

Am J Obstet Gynecol. 2003 Jun;188(6):1383-92.

PMID:
12824967
[PubMed - indexed for MEDLINE]
17.

The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer.

Castle PE, Fetterman B, Thomas Cox J, Shaber R, Poitras N, Lorey T, Kinney W.

Obstet Gynecol. 2010 Jul;116(1):76-84. doi: 10.1097/AOG.0b013e3181e3e719. Erratum in: Obstet Gynecol. 2010 Sep;116(3):775-7.

PMID:
20567171
[PubMed - indexed for MEDLINE]
18.

Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia.

Nobbenhuis MA, Meijer CJ, van den Brule AJ, Rozendaal L, Voorhorst FJ, Risse EK, Verheijen RH, Helmerhorst TJ.

Br J Cancer. 2001 Mar 23;84(6):796-801.

PMID:
11259094
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Incidence of cervical intraepithelial neoplasia grade 2 or worse in colposcopy-negative/human papillomavirus-positive women with low-grade cytological abnormalities.

Kelly RS, Walker P, Kitchener H, Moss SM.

BJOG. 2012 Jan;119(1):20-5. doi: 10.1111/j.1471-0528.2011.02970.x. Epub 2011 May 31.

PMID:
21624034
[PubMed - indexed for MEDLINE]
20.

Cervicovaginal cytology in the detection of recurrence after cervical cancer treatment.

Rimel BJ, Ferda A, Erwin J, Dewdney SB, Seamon L, Gao F, DeSimone C, Cotney KK, Huh W, Massad LS.

Obstet Gynecol. 2011 Sep;118(3):548-53. doi: 10.1097/AOG.0b013e3182271fdd.

PMID:
21860282
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk